Jian Li,Yimin Chen. Expression of PD-1/PD-L1 in lung adenocarcinoma and its clinical significance. Oncol Transl Med, 2021, 7: 15-19.
Expression of PD-1/PD-L1 in lung adenocarcinoma and its clinical significance
Received:August 09, 2020  Revised:February 27, 2021
View Full Text  View/Add Comment  Download reader
KeyWord:lung adenocarcinoma; PD-1; PD-L1; gene mutation
Author NameAffiliationE-mail
Jian Li Emeishan people''s Hospital zhongzhonglw199@aliyun.com 
Yimin Chen Department of Respiration, Emeishan People's Hospital, Emeishan 614200, China  
Hits: 3261
Download times: 5424
      Objective This study aimed to investigate PD-1/PD-L1 expression in lung adenocarcinoma and its relationship with EGFR/KRAS mutation. Methods The expression levels of PD-1 and PD-L1 in lung adenocarcinoma were detected. Clinicopathological parameters were collected and followed up. The effects of PD-1 and PD-L1 expression on clinicopathological parameters and prognosis of patients with lung adenocarcinoma were statistically analyzed. Results PD-L1 and PD-1 were mainly located in the membrane and cytoplasm of tumor cells. The positive expression rates of PD-1 and PD-L1 were 53% and 40%, respectively. Positive PD-1 expression had a significant effect on the incidence of KRAS mutation (P < 0.05), while PD-L1 expression significantly affected the incidence of EGFR mutation (P < 0.05). Overexpression of PD-1 and PD-L1 had a significant negative effect on disease-free survival (DFS) in patients with lung adenocarcinoma (P<0.05) but had no significant effect on overall survival (P > 0.05). EGFR gene mutation, high PD-1 expression, high PD-L1 expression, N stage, and AJCC stage were independent risk factors of DFS (P < 0.05). Conclusion High PD-1/PD-L1 expression is closely related to the occurrence of lung adenocarcinoma and can be used as an independent factor to assess the prognosis of patients with lung adenocarcinoma. There were negative correlations between PD-L1 expression and EGFR mutation and between PD-1 expression and KRAS mutation.